Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 29;85(4):415-425.
doi: 10.5935/0004-2749.20220053. eCollection 2021.

Brazilian guidelines for the monitoring and treatment of pediatric allergic conjunctivitis

Affiliations

Brazilian guidelines for the monitoring and treatment of pediatric allergic conjunctivitis

Cristiana Soares Ronconi et al. Arq Bras Oftalmol. .

Abstract

Allergic conjunctivitis is an increasingly frequent condition with a higher prevalence in children. It can be debilitating and is responsible for a great economic burden. These guidelines were developed on the basis of the medical literature (PubMed/Medline database) and the experience of an Expert Committee composed of members of the Brazilian Society of Pediatric Ophthalmology, the Brazilian Council of Ophthalmology, the Brazilian Society of Pediatrics, and the Brazilian Association of Allergy and Immunology. Allergic conjunctivitis is considered to be controlled when the ocular symptoms are not uncomfortable or are present, at most, on 2 days a week; the visual analog scale score is below 5; and the degree of conjunctival hyperemia is graded 0 or 1 on the Efron scale. Allergic conjunctivitis should be classified as mild, moderate, severe, and vision-threatening for adequate treatment and monitoring of frequency. The present document is a guideline for diagnosing, treating, and monitoring pediatric allergic conjunctivitis considering the clinical and demographic aspects of allergic conditions in Brazil.

A conjuntivite alérgica (CA) é uma condição frequente, debilitante e responsável por grande impacto econômico, proporcionalmente maior quando acomete crianças. Essas diretrizes foram desenvolvidas com base na literatura científica (PubMed/Medline) e na experiência de um Comitê de Especialistas composto por membros da Sociedade Brasileira de Oftalmologia Pediátrica, do Conselho Brasileiro de Oftalmologia, da Sociedade Brasileira de Pediatria e da Associação Brasileira de Alergia e Imunologia. A conjuntivite alérgica é considerada controlada quando os sintomas não são desconfortáveis ou estão presentes por dois dias na semana; o escore visual pela escala analógica é inferior a 5 e o grau de hiperemia conjuntival é de 0-1 pela escala de Efron. A conjuntivite alérgica deve ser classificada em leve, moderada, grave e com risco de perda visual para tratamento e frequência de monitoramento adequados. Esta diretriz orienta o diagnóstico, tratamento e monitoramento da conjuntivite alérgica pediátrica, considerando aspectos clínicos e demográficos das condições alérgicas no Brasil.

PubMed Disclaimer

Conflict of interest statement

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.

Figures

Figure 1
Figure 1
The Efron clinical grading scale for conjunctival and limbal hyperemia. Reprinted with permission from Efron N. Contact lens complications. 4th ed. Philadelphia: Elsevier; 2019 (ISBN: 978-0-7020-7611-4).
Figure 2
Figure 2
Algorithm for the classification and treatment of allergic conjunctivitis.

Similar articles

Cited by

  • V Brazilian Consensus on Rhinitis - 2024.
    Solé D, Kuschnir FC, Pastorino AC, Constantino CF, Galvão C, Chong E Silva DC, Baptistella E, Goudouris ES, Sakano E, Ejzenbaum F, Matsumoto FY, Mizoguchi FM, Aarestrup FM, Wandalsen GF, Chong Neto HJ, Brito de Oliveira JV, Lubianca Neto JF, Rizzo MCV, Silva Chavarria MLF, Urrutia-Pereira M, Filho NAR, de Paula Motta Rubini N, Mion O, Piltcher OB, Ramos RT, Francesco RD, Roithmann R, Anselmo-Lima WT, Romano FR, de Mello Júnior JF. Solé D, et al. Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101500. doi: 10.1016/j.bjorl.2024.101500. Epub 2024 Sep 7. Braz J Otorhinolaryngol. 2025. PMID: 39388827 Free PMC article. Review.
  • Comparison of obstructive sleep apnea syndrome and keratoconus patients on elevation maps.
    Karaca U, Akıncıoğlu D, Ayyildiz O, Dogan D, Ozge G, Usta G, Mutlu FM. Karaca U, et al. Int Ophthalmol. 2022 Mar;42(3):933-938. doi: 10.1007/s10792-021-02074-8. Epub 2021 Oct 18. Int Ophthalmol. 2022. PMID: 34661795
  • Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study.
    Li S, Zhong S. Li S, et al. Postepy Dermatol Alergol. 2023 Apr;40(2):326-330. doi: 10.5114/ada.2023.127647. Epub 2023 May 31. Postepy Dermatol Alergol. 2023. PMID: 37312902 Free PMC article.

References

    1. Japanese Ocular Allergology S . Guidelines for the clinical manage-ment of allergic conjunctival disease. 2nd. 10. Vol. 114. Nippon Ganka Gakkai Zasshi; 2010. pp. 831–870. Japanese. - PubMed
    1. Krachmer JH, Mannis MJ, Holland EJ. Cornea. 3rd. Philadelphia: Elsevier/Mosby; 2010.
    1. Geraldini M, Chong Neto HJ, Riedi CA, Rosário NA. Epidemiology of ocular allergy and co-morbidities in adolescents. J Pediatr (Rio J) 2013;89(4):354–360. - PubMed
    1. Solé D, Rosário Filho NA, Sarinho ES, Camelo-Nunes IC, Barreto BA, Medeiros ML, et al. Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003-2012) J Pediatr (Rio J) 2015;91(1):30–35. - PubMed
    1. Neto HJ, Rosário NA, Westphal GL, Riedi CA, Santos HL. Allergic conjunctivitis in asthmatic children: as common as underreported. Ann Allergy Asthma Immunol. 2010;105(5):399–400. - PubMed

LinkOut - more resources